Kinetic analysis of steroid 5α-reductase activity at neutral pH in benign prostatic hyperplastic tissue: Evidence for type I isozyme activity in the human prostate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 1-2, 1996, Pages 103-108

  Span, P N ^a   Benraad, Th J ^a   Sweep, C G J ^a   Smals, A G H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; STEROID 5ALPHA REDUCTASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MALE; PROSTATE HYPERTROPHY;

EID: 0030005247     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00167-0     Document Type: Article

References (28)

1. Russel D. W. and Wilson J. D.: Steroid 5α-reductase: two genes/two enzymes. A. Rev. Biochem. 63 (1994) 25-61.
2. Gower D. B.: 16-Unsaturated C19 steroids: a review of their chemistry, biochemistry and possible physiological role. J. Steroid Biochem. 3 (1972) 45-103.
3. Weusten J. J. A. M., Smals A. G. H., Hofman J. A., Kloppenborg P. W. C. and Benraad Th. J.: The sex pheromone precursor androsta-5,16-dien-3β-ol is a major early metabolite in in vivo pregnenolone metabolism in human testicular homogenates. J. Clin. Endocr. Metab. 65 (1987) 753-756.
4. Wilson J. D.: The pathogenesis of benign prostatic hyperplasia. Am. J. Med. 68 (1980) 745-756.
5. Krieg M., Bartsch W., Thomsen M. and Voigt K. D.: Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate. J. Steroid Biochem. 19 (1983) 155-161.
6. Rennie P. S., Bruchovsky N., McLoughlin M. G., Batzold F. H. and Dunstan-Adams E. E.: Kinetic analysis of 5α-reductase isoenzymes in benign prostatic hyperplasia (BPH). J. Steroid Biochem. 19 (1983) 169-173.
7. Hudson R. W.: Comparison of nuclear 5α-reductase activities in the stromal and epithelial fractions of human prostatic tissue. J. Steroid Biochem. 26 (1987) 349-353.
8. Hudson R. W. and Wherret D.: Comparison of the nuclear 5α-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia. J. Steroid Biochem. 35 (1990) 231-236.
9. Bonnet P., Reiter E., Bruyninx M., Sente B., Dombrowicz D., de Levai J., Closset J. and Hennen G.: Benign prostatic hyperplasia and normal prostate ageing: differences in type I and II 5α-reductase and steroid hormone receptor messenger ribonuclear acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J. Clin. Endocr. Metab. 77 (1993) 1203-1208.
10. Thigpen A. E., Silver R. I., Guileyardo J. M., Casey M. L., McConnell J. D. and Russell D. W.: Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J. Clin. Invest. 92 (1993) 903-910.
11. Eicheler W., Tuohimaa P., Vilja P., Adermann K., Forssmann W.-G. and Aumüller G.: Immunocytochemical localization of human 5α-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J. Histochem. Cytochem. 42 (1994) 667-675.
12. Silver R. I., Wiley E. L., Davis D. L., Thigpen A. E., Russell D. W. and McConnell J. D.: Expression and regulation of steroid 5α-reductase 2 in prostatic disease. J. Urol. 152 (1994) 433-437.
13. Jenkins E. P., Andersson S., Imperato-McGinley J., Wilson J. D. and Russell D. W.: Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J. Clin. Invest. 89 (1992) 293-300.
14. Wilson J. D., Griffin J. E. and Russell D. W.: Steroid 5α-reductase 2 deficiency. Endocrine Rev. 14 (1993) 577-593.
15. Fratianni C. M. and Imperato-McGinley J.: The syndrome of 5α-reductase deficiency. Endocrinologist 4 (1994) 302-314.
16. Andersson S. and Russell D. W.: Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. Natn. Acad. Sci. 87 (1990) 3640-3644.
17. Hudson R. W.: Studies of the nuclear 5α-reductase of human hyperplastic prostatic tissue. J. Steroid Biochem. 14 (1980) 579-584.
18. 4-3-ketosteroid 5α-oxidoreductases (5α-reductases) in human prostate. Experientia 49 (1993) A38.
19. Thigpen A. E., Cala K. M. and Russell D. W.: Characterization of Chinese hamster ovary cell lines expressing human steroid 5α-reductase isozymes. J. Biol. Chem. 268 (1993) 17,404-17,412.
20. Span P. N., Benraad Th. J., Sweep C. G. J. and Smals A. G. H.: Kinetic analysis of rat steroid 5α-reductase activity in prostate and epididymis homogenates at neutral pH: evidence for type I activity in epididymis. J. Steroid Biochem. Molec. Biol. 57, No. 1 1996.
21. Segal I. H.: Enzyme Kinetics. John Wiley & Sons, New York (1975) p. 70 and pp. 214-218.
22. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275.
23. Span P. N., Smals A. G. H., Sweep C. G. J. and Benraad Th. J.: Rat steroid 5α-reductase kinetic characteristics: extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates. J. Steroid Biochem. Molec. Biol. 54 (1995) pp. 185-192.
24. Liang T., Cascieri M. A., Cheung A. H., Reynolds G. F. and Rasmusson G. H.: Species differences in prostatic steroid 5α-reductases of rat, dog, and human. Endocrinology 117 (1985) 571-579.
25. Wigley W. C., Prihoda J. S., Mowszowicz I., Mendonca B. B., New M. I., Wilson J. D. and Russell D. W.: Natural mutagenesis study of the human steroid 5α-reductase II isozyme. Biochemistry 33 (1994) 1265-1270.
26. Martin P. M., Le Goff J. M., Brisset J. M., Ojasoo T., Husson J. M. and Raynaud J. P.: Use and limitations of hormone, receptor and enzyme assays in prostate cancer. Prog. Clin. Biol. Res. 243A (1987) 111-140.
27. Faller B., Farley D. and Nick H. P.: Finasteride: a slow-binding 5α-reductase inhibitor. Biochemistry 32 (1993) 5705-5710.
28. Houston B., Chisholm G. D. and Habib F. K.: Evidence that human prostatic 5α-reductase is located exclusively in the nucleus. FEBS 185 (1985) 231-235.